Profound Medical Corp. (PROF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on March 10, 2026, covering events occurring on March 5, 2026. The Company is incorporated in Ontario, Canada, and its common shares trade on The Nasdaq Stock Market under the symbol "PROF".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: Kris Shah resigned from the Board of Directors effective immediately on March 5, 2026. The resignation was not the result of any disagreement with the Company.
- Director Appointment: Frank Baylis was appointed to the Board to fill the vacancy created by Mr. Shah's resignation. He will serve until the 2026 annual meeting of stockholders or until his successor is elected.
- Compensation: Mr. Baylis is entitled to the standard non-employee director compensation, including an annual retainer of $50,000 (prorated) and eligibility for an annual equity award.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific business risks. It confirms there are no undisclosed family relationships or material transactions involving Mr. Baylis requiring disclosure under Item 404(a) of Regulation S-K. Mr. Baylis has entered into the Company's standard indemnification agreement.
Investor Verification Checklist
- Verify the effective date of Kris Shah's resignation and the immediate appointment of Frank Baylis.
- Confirm the compensation structure for Mr. Baylis, specifically the $50,000 annual retainer and equity eligibility.
- Review the Company's proxy statement or subsequent filings for the composition of the Board leading up to the 2026 annual meeting.
- Check for any undisclosed disagreements or material interests related to the departing or incoming director.